Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 156

1.

An evaluation of mepolizumab for the treatment of severe asthma.

Morjaria JB, Emma R, Fuochi V, Polosa R, Caruso M.

Expert Opin Biol Ther. 2019 Apr 22:1-10. doi: 10.1080/14712598.2019.1610382. [Epub ahead of print]

PMID:
31009582
2.

Improving neurocognitive functioning in schizophrenia by addition of cognitive remediation therapy to a standard treatment of metacognitive training.

Caponnetto P, Maglia M, Auditore R, Bocchieri M, Caruso A, DiPiazza J, Polosa R.

Ment Illn. 2018 Dec 20;10(2):7812. doi: 10.4081/mi.2018.7812. eCollection 2018 Nov 6.

3.

Mepolizumab in the management of severe eosinophilic asthma in adults: current evidence and practical experience.

Emma R, Morjaria JB, Fuochi V, Polosa R, Caruso M.

Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618808490. doi: 10.1177/1753466618808490. Review.

4.

Commentary: Inflammatory and Oxidative Responses Induced by Exposure to Commonly Used e-Cigarette Flavoring Chemicals and Flavored e-Liquids without Nicotine.

Caruso M, Li Volti G, Furneri PM, Fuochi V, Emma R, Polosa R.

Front Physiol. 2018 Sep 13;9:1240. doi: 10.3389/fphys.2018.01240. eCollection 2018. No abstract available.

5.

Health effects in COPD smokers who switch to electronic cigarettes: a retrospective-prospective 3-year follow-up.

Polosa R, Morjaria JB, Prosperini U, Russo C, Pennisi A, Puleo R, Caruso M, Caponnetto P.

Int J Chron Obstruct Pulmon Dis. 2018 Aug 22;13:2533-2542. doi: 10.2147/COPD.S161138. eCollection 2018.

6.

Electronic cigarette vapour enhances pneumococcal adherence to airway epithelial cells under abnormal conditions of exposure.

Caruso M, Emma R, Fuochi V, Furneri PM, Polosa R.

Eur Respir J. 2018 Sep 6;52(3). pii: 1800915. doi: 10.1183/13993003.00915-2018. Print 2018 Sep. No abstract available.

PMID:
30190260
7.

Carbon monoxide levels after inhalation from new generation heated tobacco products.

Caponnetto P, Maglia M, Prosperini G, Busà B, Polosa R.

Respir Res. 2018 Aug 31;19(1):164. doi: 10.1186/s12931-018-0867-z.

8.

Basophil biomarkers as useful predictors for sublingual immunotherapy in allergic rhinitis.

Caruso M, Cibella F, Emma R, Campagna D, Tringali G, Amaradio MD, Polosa R.

Int Immunopharmacol. 2018 Jul;60:50-58. doi: 10.1016/j.intimp.2018.04.034. Epub 2018 Apr 25.

PMID:
29702283
9.

Frequency of Use and Smoking Status of U.S. Adolescent E-Cigarette Users in 2015.

Farsalinos K, Tomaselli V, Polosa R.

Am J Prev Med. 2018 Jun;54(6):814-820. doi: 10.1016/j.amepre.2018.03.003. Epub 2018 Apr 7.

PMID:
29631871
10.

Treatment of Allergic Rhinitis as a Strategy for Preventing Asthma.

Morjaria JB, Caruso M, Emma R, Russo C, Polosa R.

Curr Allergy Asthma Rep. 2018 Mar 24;18(4):23. doi: 10.1007/s11882-018-0781-y. Review.

PMID:
29574527
11.

Lack of Substantial Post-Cessation Weight Increase in Electronic Cigarettes Users.

Russo C, Cibella F, Mondati E, Caponnetto P, Frazzetto E, Caruso M, Caci G, Polosa R.

Int J Environ Res Public Health. 2018 Mar 23;15(4). pii: E581. doi: 10.3390/ijerph15040581.

12.

E-Cigarette and COPD: Unreliable Conclusion About Health Risks.

Cummings KM, Polosa R.

J Gen Intern Med. 2018 Jun;33(6):784-785. doi: 10.1007/s11606-018-4396-8. No abstract available.

PMID:
29564607
13.

Assessment of E-cigarette impact on smokers: The importance of experimental conditions relevant to human consumption.

Li Volti G, Polosa R, Caruso M.

Proc Natl Acad Sci U S A. 2018 Apr 3;115(14):E3073-E3074. doi: 10.1073/pnas.1801967115. Epub 2018 Mar 13. No abstract available.

14.

Training pharmacists in the stage-of-change model of smoking cessation and motivational interviewing: A randomized controlled trial.

Caponnetto P, DiPiazza J, Aiello MR, Polosa R.

Health Psychol Open. 2017 Oct 28;4(2):2055102917736429. doi: 10.1177/2055102917736429. eCollection 2017 Jul-Dec.

15.

E-cigarettes unlikely to raise significant health concerns in airways disease.

Polosa R.

Respirology. 2018 Apr;23(4):435-436. doi: 10.1111/resp.13256. Epub 2018 Jan 9. No abstract available.

PMID:
29316603
16.

Biologic agents for severe asthma patients: clinical perspectives and implications.

Caruso M, Morjaria J, Emma R, Amaradio MD, Polosa R.

Intern Emerg Med. 2018 Mar;13(2):155-176. doi: 10.1007/s11739-017-1773-y. Epub 2017 Dec 14. Review.

PMID:
29238905
17.

Are we addressing relevant determinants of smoking cessation?

Caponnetto P, Polosa R.

Eur Respir J. 2017 Nov 22;50(5). pii: 1701615. doi: 10.1183/13993003.01615-2017. Print 2017 Nov. No abstract available.

18.

Health impact of E-cigarettes: a prospective 3.5-year study of regular daily users who have never smoked.

Polosa R, Cibella F, Caponnetto P, Maglia M, Prosperini U, Russo C, Tashkin D.

Sci Rep. 2017 Nov 17;7(1):13825. doi: 10.1038/s41598-017-14043-2.

19.

Perplexing Conclusions Concerning Heat-Not-Burn Tobacco Cigarettes.

Caruso M, Polosa R.

JAMA Intern Med. 2017 Nov 1;177(11):1699. doi: 10.1001/jamainternmed.2017.5843. No abstract available.

PMID:
29114793
20.

Letter to the Editor: Pulmonary toxicity of electronic cigarettes: more doubts than certainties.

Caruso M, Mendelsohn CP, Polosa R.

Am J Physiol Lung Cell Mol Physiol. 2017 Nov 1;313(5):L964-L965. doi: 10.1152/ajplung.00402.2017. No abstract available.

Supplemental Content

Loading ...
Support Center